What were the results of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI) in-hospital and 1-year follow-up?
The results of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI) in-hospital showed that coronary angioplasty was associated with a higher mortality rate than coronary artery bypass surgery. The 1-year follow-up of the ERACI trial revealed that the mortality rate was lower for patients who underwent coronary angioplasty than for those who had coronary artery bypass surgery. Furthermore, coronary angioplasty was found to be cost-effective compared with coronary artery bypass grafting.